Rivaroxaban monotherapy noninferior in atrial fibrillation and stable coronary disease
Medical News Archived, TheSynapse Online
Rivaroxaban monotherapy is noninferior to combination therapy in patients with atrial fibrillation and stable coronary artery disease either not requiring intervention or more than one year after revascularisation. The late breaking results of the AFIRE study were presented in a Hot Line Session today at…
Long-Term Use of Aspirin Doesn’t Lower Risk of Stroke in Some Patients with Atrial Fibrillation
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City found that using long-term aspirin therapy to prevent strokes among patients who are considered to be at low risk for stroke may not be effective as previously thought.The study…
Sponsor Message
Tags
adoloscence
cancer
cannabis
Cardiology
Contribution
dementia
Dentistry
Dermatology
Dermfest
Editorial
endocrinology
environmental health
exercise
Family Medicine
Francesco Carelli
gastroenterology
genetics
Geriatrics
gynaecology
hypertension
infections
Infectious Diseases
Medical Education
Medical Ethics
Medicine and the arts
microbionta
Neurology
Nutrition
obesity
obstetrics
Oncology
Orthopaedics
Paediatrics
Pharmacology
Pharmacy Practice
Psychiatry
Public Health
Radiology
Respiratory Medicine
Rheumatology
smoking
Surgery
TheSynapse Interview
Urology
Women's health